Hysteroscopy Procedures Market Report 2026

The hysteroscopy procedures market size has grown strongly in recent years. It will grow from $4.32 billion in 2025 to $4.64 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing prevalence of abnormal uterine bleeding, rising awareness of minimally invasive diagnostics, improved access to gynecological care, growth in hospital-based surgical procedures, advancements in optical and imaging technologies.

The hysteroscopy procedures market size is expected to see strong growth in the next few years. It will grow to $6.23 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rising demand for fertility evaluation procedures, expansion of ambulatory surgery centers, increasing preference for outpatient diagnostics, technological innovation in flexible hysteroscopes, growing healthcare expenditure on women’s health. Major trends in the forecast period include growing adoption of minimally invasive gynecological procedures, increasing shift toward office-based and outpatient hysteroscopy, rising demand for diagnostic hysteroscopy in infertility management, technological advancements in hysteroscopic visualization and instruments, expanding use of hysteroscopy for early detection of uterine disorders.

The rising prevalence of gynecological problems is expected to drive the growth of the hysteroscopy procedure market in the coming years. Gynecological disorders are conditions that affect the normal functioning of the female reproductive system, such as uterine fibroids, menstrual disorders, or polycystic ovarian syndrome. Hysteroscopy techniques can help detect and treat issues that cause abnormal uterine bleeding, excessive menstrual bleeding, irregular spotting between periods, and postmenopausal bleeding, potentially reducing the frequency and severity of gynecological illnesses. For example, in January 2023, the National Center for Biotechnology Information reported that over 70% of women will have uterine fibroids by menopause, and 25% of women of reproductive age will have clinically detectable uterine fibroids. Additionally, in March 2023, the World Health Organization reported that endometriosis affects nearly 10% (190 million) of reproductive-age women and girls worldwide. Consequently, the growing prevalence of gynecological problems is driving the hysteroscopy procedure market.

Key companies in the hysteroscopy procedures market are focusing on innovative solutions, such as hysteroscopic tissue removal systems, to make procedures minimally invasive and more efficient. A hysteroscopic tissue removal system is a medical device used to resect or remove abnormal tissues within the uterus while providing real-time visualization for precise treatment. For instance, in July 2023, GenWorks Health Private Limited, an India-based medical equipment company, launched a mechanical hysteroscopic tissue removal system. This device allows minimally invasive extraction of intrauterine tissues during hysteroscopic procedures using soft tissue shavers that cut and aspirate abnormal tissues, such as endometrial fibroids and polyps, simultaneously. The system provides direct visualization of the intrauterine cavity, enabling accurate targeting and collection of tissue for pathological analysis. By reducing reliance on energy discharge and minimizing fluid usage, the device improves both safety and efficiency, shortens procedure times, and enhances patient outcomes, while requiring only a single insertion.

In January 2024, Stille AB, a Sweden-based medical technology company, acquired Fehling Instruments for an undisclosed amount. This acquisition aims to expand Stille AB’s surgical instrument portfolio and strengthen its capabilities in the medical devices market by integrating Fehling’s innovative solutions and expertise. Fehling Instruments, based in Germany, specializes in developing and manufacturing precision instruments and medical devices for surgical applications.

Major companies operating in the hysteroscopy procedures market are Hologic Inc., CooperSurgical Inc., Stryker Corp., Karl Storz SE & Co. KG, Medtronic plc, Johnson & Johnson Services Inc., Olympus Corporation, B. Braun SE, Richard Wolf GmbH, Erbe Elektromedizin GmbH, Boston Scientific Corporation, MedGyn Products Inc., LiNA Medical ApS, LUMINELLE, Meditrina Inc., Maxer Endoscopy GmbH, Smith & Nephew plc, Cook Medical LLC, Fujifilm Holdings Corporation, ConMed Corporation, Silex Medical LLC, Endo Optiks Inc.

North America was the largest region in the hysteroscopy procedure market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global hysteroscopy procedure market report during the forecast period. The regions covered in the hysteroscopy procedures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hysteroscopy procedures market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the hysteroscopy procedures market by increasing the cost of imported hysteroscopes, surgical instruments, and optical components, impacting procurement budgets for hospitals and ambulatory surgery centers. Regions dependent on imported medical devices, particularly Asia-Pacific and parts of Latin America, are more affected by these cost pressures. However, tariffs are also encouraging local manufacturing, supplier diversification, and investments in cost-efficient device innovation, supporting long-term market resilience.

The hysteroscopy procedures market research report is one of a series of new reports that provides hysteroscopy procedures market statistics, including hysteroscopy procedures industry global market size, regional shares, competitors with a hysteroscopy procedures market share, detailed hysteroscopy procedures market segments, market trends and opportunities, and any further data you may need to thrive in the hysteroscopy procedures industry. This hysteroscopy procedures market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hysteroscopy is a diagnostic procedure that allows a surgeon to examine the interior of the uterus. It is performed using a hysteroscope to investigate symptoms or conditions such as heavy menstrual bleeding, abnormal vaginal bleeding, postmenopausal bleeding, pelvic pain, recurrent miscarriages, or difficulties in conceiving.

The primary product types used in hysteroscopy procedures include flexible hysteroscopes, rigid hysteroscopes, forceps, and scissors. Flexible hysteroscopes offer a safe, effective, and reliable method for evaluating abnormal uterine bleeding. These instruments are applied in various procedures, including hysteroscopy, endometrial ablation, myomectomy, polypectomy, and others, and are utilized by end-users such as hospitals, clinics, ambulatory surgery centers, and other healthcare facilities.

The hysteroscopy procedure market consists of revenues earned by entities by providing diagnostic and operative hysteroscopy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The hysteroscopy procedures market consists of sales of hysteroscopes, hysterosheaths, and hysteroscopic tissue removal systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.